BALPHARMA Financial Statements

BALPHARMA Annual Results

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 46.40 (18) (8.60) 15.40
Op profit growth 414 (72) 16.30 (0.30)
EBIT growth (1,593) (109) 6.98 24.50
Net profit growth (139) (539) 58.30 25
Profitability ratios (%)        
OPM 9.76 2.78 8.23 6.47
EBIT margin 6.42 (0.60) 5.81 4.96
Net profit margin 1.89 (7.10) 1.33 0.77
RoCE 9.41 (0.60) 7.12 7.22
RoNW 2.24 (5.20) 1.09 0.75
RoA 0.69 (1.70) 0.41 0.28
Per share ratios ()        
EPS 3.18 (9.10) 0.27 --
Dividend per share 1 -- 1 1
Cash EPS (3.20) (14) (2.80) (3.30)
Book value per share 36.10 37 45.90 44.10
Valuation ratios        
P/E 16.90 (3.60) 286 --
P/CEPS (17) (2.30) (27) (26)
P/B 1.49 0.88 1.68 2.01
EV/EBIDTA 7.26 24.50 11.30 12
Payout (%)        
Dividend payout -- -- 50.90 80.60
Tax payout 14.90 (4.70) (87) (114)
Liquidity ratios        
Debtor days 85.10 121 110 94.70
Inventory days 93.30 143 106 76.90
Creditor days (84) (119) (108) (88)
Leverage ratios        
Interest coverage (1.30) 0.09 (1.30) (1.30)
Net debt / equity 1.98 2.20 1.62 1.42
Net debt / op. profit 4.34 24.20 6.12 5.97
Cost breakup ()        
Material costs (60) (49) (47) (51)
Employee costs (17) (29) (23) (20)
Other costs (13) (19) (22) (23)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 251 171 209 229
yoy growth (%) 46.40 (18) (8.60) 15.40
Raw materials (151) (84) (99) (116)
As % of sales 60.30 49.20 47.30 50.80
Employee costs (42) (50) (47) (45)
As % of sales 16.70 29.50 22.50 19.80
Other costs (33) (32) (46) (53)
As % of sales 13.30 18.60 21.90 22.90
Operating profit 24.50 4.76 17.20 14.80
OPM 9.76 2.78 8.23 6.47
Depreciation (9.50) (7.70) (6.80) (6.50)
Interest expense (12) (12) (9.30) (8.50)
Other income 1.14 1.84 1.70 3.04
Profit before tax 4.10 (14) 2.88 2.87
Taxes 0.61 0.64 (2.50) (3.30)
Tax rate 14.90 (4.70) (87) (114)
Minorities and other 0.03 0.67 2.41 2.15
Adj. profit 4.74 (12) 2.78 1.76
Exceptional items -- -- -- --
Net profit 4.74 (12) 2.78 1.76
yoy growth (%) (139) (539) 58.30 25
NPM 1.89 (7.10) 1.33 0.77
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 4.10 (14) 2.88 2.87
Depreciation (9.50) (7.70) (6.80) (6.50)
Tax paid 0.61 0.64 (2.50) (3.30)
Working capital 46.60 37.60 19.60 --
Other operating items -- -- -- --
Operating cashflow 41.80 17 13.20 (6.90)
Capital expenditure 15 2.56 (21) --
Free cash flow 56.80 19.60 (8.20) (6.90)
Equity raised 76.70 94.10 92.80 96.20
Investments -- -- -- --
Debt financing/disposal 63.20 72.60 62.90 --
Dividends paid -- -- 1.42 1.42
Other items -- -- -- --
Net in cash 197 186 149 90.70
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 15.80 14.20 14.20 14.20
Preference capital -- -- -- --
Reserves 37.80 38.30 52.50 50.80
Net worth 53.60 52.40 66.60 65
Minority interest
Debt 110 118 124 110
Deferred tax liabilities (net) 7.15 7.49 5.82 8.53
Total liabilities 171 171 190 178
Fixed assets 68.60 74 74 71.70
Intangible assets
Investments -- -- 0.02 0.02
Deferred tax asset (net) 4.51 3.90 1.64 0.96
Net working capital 93.60 90.20 110 101
Inventories 60.40 67.70 69.80 66.50
Inventory Days 88 144 -- 116
Sundry debtors 67.20 49.60 64.70 64.10
Debtor days 97.90 106 -- 112
Other current assets 40.10 43.90 48.50 53.80
Sundry creditors (53) (50) (56) (58)
Creditor days 77.60 107 -- 102
Other current liabilities (21) (21) (17) (25)
Cash 3.85 3.13 4.32 4.15
Total assets 171 171 190 178
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017
Gross Sales 251 171 225 211 235
Excise Duty -- -- -- -- --
Net Sales 251 171 225 211 235
Other Operating Income -- -- -- -- --
Other Income 1.14 1.85 1.01 1.70 2.97
Total Income 252 173 226 213 238
Total Expenditure ** 226 166 208 194 221
PBIDT 25.60 6.60 18.50 18.90 17.30
Interest 12 12.50 12.60 9.27 8.49
PBDT 13.60 (5.90) 5.95 9.65 8.85
Depreciation 9.52 7.68 6.16 6.77 6.49
Minority Interest Before NP -- -- -- -- --
Tax (0.60) (0.60) (2.40) 2.51 3.10
Deferred Tax -- -- -- -- --
Reported Profit After Tax 4.71 (13) 2.15 0.38 (0.70)
Minority Interest After NP -- (0.70) -- -- --
Net Profit after Minority Interest 4.74 (12) 2.15 0.38 (0.70)
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 4.74 (12) 2.15 0.38 (0.70)
EPS (Unit Curr.) 3.34 (8.60) 1.52 0.27 (0.50)
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) 10 -- 10 10 10
Equity 14.80 14.20 14.20 14.20 14.20
Public Shareholding (Number) -- -- -- -- 7,886,570
Public Shareholding (%) -- -- -- -- 55.70
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- 6,085,802
Non Encumbered - % in Total Promoters Holding -- -- -- -- 100
Non Encumbered - % in Total Equity -- -- -- -- 44.40
PBIDTM(%) 10.20 3.86 8.23 8.95 7.38
PBDTM(%) 5.44 (3.40) 2.64 4.56 3.77
PATM(%) 1.88 (7.50) 0.96 0.18 (0.30)
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity